Meet the Experts: Non-invasive assessment in NAFLD

 Metabolism, alcohol and toxicity

Channel 3

Meet the Experts
27 August 2020 19:00 - 19:30

Questions sor discussion: 

  1. Is there a case for screening for liver fibrosis among patients with obesity or diabetes, or even the general population?
  2. How do we adress LSM false positives in NAFLD? Should we do parallel or sequential testing combining LSM with a serum marker?
  3. How far are we with predictive markers for NAFLD trials?